Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$1.00+ here we come. Required for compliance. RS voted down. BOOM!!!
U keep praying this one is going
I pray that the hospitals are paying for it.
Q1 earnings transcript
In the past six weeks, we have provided over 20 Aquadex consoles as loaners to several hospitals in the COVID-19 hotspots.
https://seekingalpha.com/article/4346605-chf-solutions-chfs-ceo-john-erb-on-q1-2020-results-earnings-call-transcript?page=2
You still think we are in that silent period lol
News today and a tweet in same day wow
Strong buy wow
A
M
A
Z
I
N
G
Tweet just out - @CHFS_Aquadex usage to stabilize #COVID19 patients has grown in Florida due to the second wave of the virus. 3 new hospitals in Central Florida just added #ultrafiltration as an alternative therapy for fluid management.
“Did that just freeze any additional news until the earnings call?”
lol I guess not WE GOT NEWS TODAY
Today’s news is amazing I like the pre market pop
CHFS is expanding its presence and distribution globally. This means sales and revenue. They intentionally excludes the USA, another huge market, to focus attention on the global expansion.
“Ultrafiltration therapy is now available in 16 countries outside the U.S.”
Please explain what this means for CHFS?
*** Ultrafiltration therapy is now available in 16 countries outside the U.S.
CHF Solutions Further Expands Commercial Presence in the Middle East with Distribution Arrangement for Israel and Palestine
July 30 2020 - 12:00PM
CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region. Ultrafiltration therapy is now available in 16 countries outside the U.S.
Ninety percent of hospitalizations among heart failure patients are due to signs and symptoms of fluid overload,1 and approximately two percent of the Israeli population suffers from heart failure.2 The Aquadex SmartFlow System is a simple, flexible and smart fluid management platform using ultrafiltration to stabilize patients experiencing fluid overload, giving providers the ability to manage their patients’ fluid balance with precision, control and ease.
“CHF Solutions is committed to making ultrafiltration therapy available for patients throughout the world. Our partnership with SysteMedic demonstrates continued execution on that strategy,” said John Erb, chairman and CEO of CHF Solutions. “Subject to regulatory approval, we look forward to working with SysteMedic to make the simple, flexible and smart Aquadex SmartFlow™ system available to patients in Israel and Palestine suffering from fluid overload due to heart failure, cardiovascular surgery and other critical care conditions.”
“We are very excited to work with CHF Solutions to introduce their ultrafiltration technology to Israel and Palestine,” said Arik Yanco, General Manager of SysteMedic. “We believe the Aquadex therapy will make a difference in the quality of lives of patients and look forward to a successful partnership.”
CHF Solutions Further Expands Commercial Presence in the Middle East with Distribution Arrangement for Israel and Palestine - https://www.bloomberg.com/press-releases/2020-07-30/chf-solutions-further-expands-commercial-presence-in-the-middle-east-with-distribution-arrangement-for-israel-and-palestine
CHF Solutions Further Expands Commercial Presence in the Middle East with
Distribution Arrangement for Israel and Palestine
EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq:
CHFS) today announced the signing of a distribution agreement with SysteMedic
Ltd., covering Israel and Palestine, representing the second distribution
partnership in the Middle East region. Ultrafiltration therapy is now
available in 16 countries outside the U.S.
Ninety percent of hospitalizations among heart failure patients are due to
signs and symptoms of fluid overload,^1 and approximately two percent of the
Israeli population suffers from heart failure.^2 The Aquadex SmartFlow System
is a simple, flexible and smart fluid management platform using
ultrafiltration to stabilize patients experiencing fluid overload, giving
providers the ability to manage their patients’ fluid balance with precision,
control and ease.
“CHF Solutions is committed to making ultrafiltration therapy available for
patients throughout the world. Our partnership with SysteMedic demonstrates
continued execution on that strategy,” said John Erb, chairman and CEO of CHF
Solutions. “Subject to regulatory approval, we look forward to working with
SysteMedic to make the simple, flexible and smart Aquadex SmartFlow™ system
available to patients in Israel and Palestine suffering from fluid overload
due to heart failure, cardiovascular surgery and other critical care
conditions.”
“We are very excited to work with CHF Solutions to introduce their
ultrafiltration technology to Israel and Palestine,” said Arik Yanco, General
Manager of SysteMedic. “We believe the Aquadex therapy will make a difference
in the quality of lives of patients and look forward to a successful
partnership.”
^1 Costanzo MR et al. JACC. 2017;69(19):2428-45.
^2 www.health.gov.il/PublicationsFiles/health2013.pdf.
Besides this isn't a earnings play it's a growth Covid play
That's TUESDAY lol a few trading days away we can all wait for good news till Tuesday, why try to scare the board
today's news is not what we wanted. The earnings date.
Did that just freeze any additional news until the earnings call?
CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2020 financial results will be released on Tuesday, August 4, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the Investors page of the CHF Solutions website at http://ir.chf-solutions.com or access the webcast directly at http://ir.chf-solutions.com/events. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 3591247. An audio archive of the webcast will be available following the call on the Investor page at http://ir.chf-solutions.com/events.
See post # 1482 for more info on final vote, 6/19.
R/S proposal was not approved.
CHFS
Nice early morning action on CHFS
CHFS
Maybe I answered my own question:
Stockholders have thus far strongly supported Proposal 3. At the time of the meeting, approximately 56% of the shares that had been voted on Proposal 3 had been voted in its favor. However, the favorable votes were less than the absolute majority of all outstanding shares needed for approval. Proposals 1, 2 and 4 were approved at the Annual Meeting.
What can anyone tell me about this:
EDEN PRAIRIE, Minn., May 22, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq:CHFS) (“CHF Solutions”) today announced that its 2020 Annual Meeting of Stockholders held on May 20, 2020 convened and then adjourned until June 19, 2020 2:00 p.m. US Central Time at https://web.lumiagm.com/257409059 to solicit additional proxies for Proposal 3, granting the Board of Directors the discretion to implement a reverse stock split (“Proposal 3”).[color=red][/color]
The Board of Directors believes approval of Proposal 3 is in the best interests of CHF Solutions and its stockholders because a reverse stock split may be necessary to maintain the listing of CHF Solutions’ common stock on the NASDAQ Capital Market (“Nasdaq”). A delisting of the common stock from Nasdaq could significantly impair CHF Solutions’ ability to raise additional capital, which may be needed to operate its business; it could result in lower prices for its common stock and larger spreads in the bid and ask prices for the common stock; and it could impact a stockholders ability to trade shares of common stock. Proposal 3 is described in more detail in the company’s proxy statement, dated April 13, 2020 (the “Proxy Statement”), furnished to stockholders in connection with the 2020 Annual Meeting. As stated in the Proxy Statement, CHF Solutions only intends to implement the reverse stock split if needed to maintain its listing on Nasdaq.
Stockholders have thus far strongly supported Proposal 3. At the time of the meeting, approximately 56% of the shares that had been voted on Proposal 3 had been voted in its favor. However, the favorable votes were less than the absolute majority of all outstanding shares needed for approval. Proposals 1, 2 and 4 were approved at the Annual Meeting.
* * $CHFS Video Chart 07-24-2020 * *
Link to Video - click here to watch the technical chart video
I'm expecting to see the $1+, sometime, next week.
CHFS
I would be happier if they said they sold those devices instead of loaned.
I called Lewis at CHFS , IR Dept he says stock needs to and will be over a dollar ASAP more hospital news Monday or Tuesday
Weeeeeeeeeeeeeeeeeeeeeeeeeeeeeeee
CHFS
Monster move today.
More coming.
CHFS
Wow CHFS flying WHATS the news rumor is there product is now in 450 florida hospitals wow company already said no R/S coming there for we must go over a buck dollar land here we come
Giasou patrida.....weeeeeeeeeeeeeeee
Just keeps on moving up....tons of upside here for sure.
CHFS
CHFS wins its 2nd international patent all in the same day!!!!!!! HUGE NEWS and no PR yet!!!!! https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020142454
Increased orders and two patents can we get $1?
Just monster updates here.....fantastic !!!
CHFS
Make that TWO new International Patents!
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020142454
CHFS just received new International patent for their blood filtration systems :)
https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020142533
Another lovely pop.....show me the money
CHFS
This stock is sitting just under .60 which is far below 4.50...lol.
More from web conference: Units sell for 35k each. First sale was in April 2020. They continue to receive orders from Florida accounts.
Followers
|
64
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1655
|
Created
|
07/06/12
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads